ThermoDox heat-activated liposome: Updated Phase I/II data

Data from 13 evaluable patients with recurrent chest wall breast cancer in the Phase II portion of the open-label, U.S. Phase I/II DIGNITY trial showed that ThermoDox plus mild local hyperthermia led ...